271 related articles for article (PubMed ID: 38038882)
41. Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods.
Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Brixen K; Mosekilde L
Clin Endocrinol (Oxf); 2008 Nov; 69(5):713-20. PubMed ID: 18410554
[TBL] [Abstract][Full Text] [Related]
42. GCM2-Activating Mutations in Familial Isolated Hyperparathyroidism.
Guan B; Welch JM; Sapp JC; Ling H; Li Y; Johnston JJ; Kebebew E; Biesecker LG; Simonds WF; Marx SJ; Agarwal SK
Am J Hum Genet; 2016 Nov; 99(5):1034-1044. PubMed ID: 27745835
[TBL] [Abstract][Full Text] [Related]
43. Pro-FHH: A Risk Equation to Facilitate the Diagnosis of Parathyroid-Related Hypercalcemia.
Bertocchio JP; Tafflet M; Koumakis E; Maruani G; Vargas-Poussou R; Silve C; Nissen PH; Baron S; Prot-Bertoye C; Courbebaisse M; Souberbielle JC; Rejnmark L; Cormier C; Houillier P
J Clin Endocrinol Metab; 2018 Jul; 103(7):2534-2542. PubMed ID: 29727008
[TBL] [Abstract][Full Text] [Related]
44. Genetic analyses in familial isolated hyperparathyroidism: implication for clinical assessment and surgical management.
Cetani F; Pardi E; Ambrogini E; Lemmi M; Borsari S; Cianferotti L; Vignali E; Viacava P; Berti P; Mariotti S; Pinchera A; Marcocci C
Clin Endocrinol (Oxf); 2006 Feb; 64(2):146-52. PubMed ID: 16430712
[TBL] [Abstract][Full Text] [Related]
45. A patient with primary hyperparathyroidism associated with familial hypocalciuric hypercalcemia induced by a novel germline CaSR gene mutation.
Yabuta T; Miyauchi A; Inoue H; Yoshida H; Hirokawa M; Amino N
Asian J Surg; 2009 Apr; 32(2):118-22. PubMed ID: 19423460
[TBL] [Abstract][Full Text] [Related]
46. Low urine calcium excretion in African American patients with primary hyperparathyroidism.
Taha W; Singh N; Flack JM; Abou-Samra AB
Endocr Pract; 2011; 17(6):867-72. PubMed ID: 21613053
[TBL] [Abstract][Full Text] [Related]
47.
Szalat A; Shpitzen S; Pollack R; Mazeh H; Durst R; Meiner V
Front Endocrinol (Lausanne); 2023; 14():1254156. PubMed ID: 38130397
[TBL] [Abstract][Full Text] [Related]
48. Case Report: Severe Neonatal Course in Paternally Derived Familial Hypocalciuric Hypercalcemia.
Höppner J; Lais S; Roll C; Wegener-Panzer A; Wieczorek D; Högler W; Grasemann C
Front Endocrinol (Lausanne); 2021; 12():700612. PubMed ID: 34659108
[TBL] [Abstract][Full Text] [Related]
49. Calcium homeostasis and hyperparathyroidism: Nephrologic and endocrinologic points of view.
Lemoine S; Figueres L; Bacchetta J; Frey S; Dubourg L
Ann Endocrinol (Paris); 2022 Aug; 83(4):237-243. PubMed ID: 35598638
[TBL] [Abstract][Full Text] [Related]
50. A novel CASR variant in a family with familial hypocalciuric hypercalcaemia and primary hyperparathyroidism.
Sagi SV; Joshi H; Trotman J; Elsey T; Swamy A; Rajkanna J; Bhat NA; Haddadin FJS; Oyibo SO; Park SM
Endocrinol Diabetes Metab Case Rep; 2020 Sep; 2020():. PubMed ID: 33434173
[TBL] [Abstract][Full Text] [Related]
51. A family case report of parathyroid carcinoma associated with
Gu Y; Ye Y; Shu H; Chang L; Xie Y; Li F; Zhu T; Liu M; He Q
Front Endocrinol (Lausanne); 2024; 15():1330185. PubMed ID: 38348418
[TBL] [Abstract][Full Text] [Related]
52. Primary hyperparathyroidism and familial hypocalciuric hypercalcemia: relationships and clinical implications.
Eldeiry LS; Ruan DT; Brown EM; Gaglia JL; Garber JR
Endocr Pract; 2012; 18(3):412-7. PubMed ID: 22232026
[TBL] [Abstract][Full Text] [Related]
53. A case of familial hypocalciuric hypercalcemia type 1 due to CASR p.Pro55Leu mutation.
Sumida A; Iizuka K; Kato T; Liu Y; Kubota S; Kubota-Okamoto S; Sakurai T; Imaizumi T; Takahashi Y; Mizuno M; Takao K; Hirota T; Suwa T; Horikawa Y; Yamamoto M; Seino Y; Suzuki A; Yabe D
BMC Endocr Disord; 2022 Jun; 22(1):164. PubMed ID: 35733207
[TBL] [Abstract][Full Text] [Related]
54. Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications.
Warner J; Epstein M; Sweet A; Singh D; Burgess J; Stranks S; Hill P; Perry-Keene D; Learoyd D; Robinson B; Birdsey P; Mackenzie E; Teh BT; Prins JB; Cardinal J
J Med Genet; 2004 Mar; 41(3):155-60. PubMed ID: 14985373
[TBL] [Abstract][Full Text] [Related]
55. Primary hyperparathyroidism in children and adolescents.
Roizen J; Levine MA
J Chin Med Assoc; 2012 Sep; 75(9):425-34. PubMed ID: 22989537
[TBL] [Abstract][Full Text] [Related]
56. Calcium-sensing receptor (CASR) mutations in hypercalcemic states: studies from a single endocrine clinic over three years.
Guarnieri V; Canaff L; Yun FH; Scillitani A; Battista C; Muscarella LA; Wong BY; Notarangelo A; D'Agruma L; Sacco M; Cole DE; Hendy GN
J Clin Endocrinol Metab; 2010 Apr; 95(4):1819-29. PubMed ID: 20164288
[TBL] [Abstract][Full Text] [Related]
57. The Biochemical Profile of Familial Hypocalciuric Hypercalcemia and Primary Hyperparathyroidism during Pregnancy and Lactation: Two Case Reports and Review of the Literature.
Ghaznavi SA; Saad NM; Donovan LE
Case Rep Endocrinol; 2016; 2016():2725486. PubMed ID: 27957351
[No Abstract] [Full Text] [Related]
58. Primary Hyperparathyroidism: Effects on Bone Health.
Zanocco KA; Yeh MW
Endocrinol Metab Clin North Am; 2017 Mar; 46(1):87-104. PubMed ID: 28131138
[TBL] [Abstract][Full Text] [Related]
59. Germline Mutations Related to Primary Hyperparathyroidism Identified by Next-Generation Sequencing.
Park HS; Lee YH; Hong N; Won D; Rhee Y
Front Endocrinol (Lausanne); 2022; 13():853171. PubMed ID: 35586626
[TBL] [Abstract][Full Text] [Related]
60. Forearm bone mineral density in familial hypocalciuric hypercalcemia and primary hyperparathyroidism: a comparative study.
Isaksen T; Nielsen CS; Christensen SE; Nissen PH; Heickendorff L; Mosekilde L
Calcif Tissue Int; 2011 Oct; 89(4):285-94. PubMed ID: 21785908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]